Detalhe da pesquisa
1.
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study.
Clin Immunol
; 229: 108786, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147649